The group aims to harness the benefits of Artificial Intelligence (AI) in oncology and haematology pharmacy while ensuring its safe and effective integration into clinical practice.
Objectives:
Reviewing Current Literature:
Examine evidence and emerging trends in AI applications relevant to oncology and haematology pharmacy.
Evaluating AI Technologies:
Assess potential benefits, risks, and challenges associated with AI adoption in pharmacy practice.
Developing Guidelines:
Formulate best practices and recommendations for ethical and responsible AI use in pharmacy, focusing on patient safety and data security.
Advising Regulatory Bodies:
Provide guidance to regulatory bodies, professional organizations, and healthcare institutions on AI implementation policies and standards.
Facilitating Education:
Promote education, training, and awareness to enhance understanding and proficiency in AI applications among pharmacists and stakeholders.
Co-Chairs: Bastiaan Buijtenhuijs and Dr Pinkie Chambers
There are several international pharmacy oncology groups working towards improving patient care and supporting pharmacists within oncology.
Explore International Groups
There are several affiliated groups with BOPA. The groups and BOPA work together jointly to promote excellence in the pharmaceutical care of patients with cancer through education, communication, research or innovation.
Explore our Affiliated Groups
There are several subcommittees & working groups that report directly to the Executive Committee each month. These subcommittees & working groups support the executive committee and keep the organisation at the forefront of care.
Meet our Subcommittees & working groups
The Executive Committee work on behalf of the BOPA members to prioritise and co-ordinate the many activities and workstreams required to achieve our goals
Meet our Executive Committee
